Development of a Cure for Diabetes and its Complications

Will the new drug be administered orally or via intravenous injection?

January 21, 2024|Categories: Development of a Cure for Diabetes and its Complications, Development of a Cure for Diabetes and its Complications in Pets, Englsih|

Is the new drug effective for Type 1 diabetes?

January 21, 2024|Categories: Development of a Cure for Diabetes and its Complications, Englsih|

What are the development costs and funding plans for the new drug?

January 21, 2024|Categories: Development of a Cure for Diabetes and its Complications, Englsih|

Is there a plan to launch the new drug in the international market?

January 21, 2024|Categories: Development of a Cure for Diabetes and its Complications, Englsih|

How is the target patient group for the new drug determined?

January 21, 2024|Categories: Development of a Cure for Diabetes and its Complications, Englsih|

What are the main challenges in the development of the new drug?

January 21, 2024|Categories: Development of a Cure for Diabetes and its Complications, Englsih|

What competitive advantage does the diabetes cure have in the market?

January 21, 2024|Categories: Development of a Cure for Diabetes and its Complications, Englsih|

Is there a development of a new diagnostic drug for diabetes?

January 21, 2024|Categories: Development of a Cure for Diabetes and its Complications, Englsih|

What about the safety of the new drug?

January 21, 2024|Categories: Development of a Cure for Diabetes and its Complications, Englsih|

When is the new drug expected to be introduced to the market?

January 21, 2024|Categories: Development of a Cure for Diabetes and its Complications, Englsih|

KIYAN Group and Collaborating Research Institutions

KIYAN PHARMA Co., Ltd.

KIYAN MEDICAL Co., Ltd.

Biozipcode, Inc.

Shiga University of Medical Science, Dep. of Regenerative Medicine

Biozipcode, Inc.

We aim to completely cure diseases rather than just offering symptomatic treatments. We focus on developing a cure for diabetes and a technology that delivers medication to specific cells (cell targeting technology called “Biozipcode”).

Learn More About Us

Contact Us

Biozipcode, Inc.

TEL:
+81-50-5534-7865

E-MAIL:
info@biozipcode.com

ADDRESS:
Seta Tsukiwa-cho, Otsu City, Shiga Prefecture
Biomedical Innovation Center, Shiga University of Medical Science, 520-2121

Languages

© Copyright 2024 Biozipcode, Inc. All Rights Reserved.